https://www.mds-foundation.org/mds-patient-family-podcastenHealth & FitnessCopyright PI Mediahttps://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/3e2ee2cf18d85ac46782f6c6a5047d8f.jpghttps://www.mds-foundation.org/mds-patient-family-podcastMon, 27 Jul 2026 10:16:38 +0000MDS FoundationPI Mediaran@podil.netPatient and family program by MDSfalse4eabc417-8b02-5b00-89d3-f3c09f58fd2cepisodichttps://www.spreaker.com/episode/inside-the-hematopathology-lab-how-bone-marrow-biopsies-shape-mds-diagnosis-and-classification-mds-patient-family-report--72249624Dr. Loghavi explains how traditional morphologic assessment is integrated with modern,  molecular testing to establish the diagnosis of myelodysplastic syndromes.]]>https://api.spreaker.com/episode/72249624Sat, 30 May 2026 16:13:37 +0000MDS FoundationJoin host Dr. Nikolaos Papadantonakis for an in-depth conversation with Dr. Sanam Loghavi of The University of Texas MD Anderson Cancer Center. In this episode, we take listeners inside the hematopathology lab to demystify what happens after a bone...Dr. Loghavi explains how traditional morphologic assessment is integrated with modern,  molecular testing to establish the diagnosis of myelodysplastic syndromes.]]>1994false52fullhttps://www.spreaker.com/episode/top-mds-updates-from-ash-2025-a-conversation-with-dr-valeria-santini-mds-patient-family-report--71116703





]]>https://api.spreaker.com/episode/71116703Sun, 05 Apr 2026 13:59:35 +0000MDS FoundationIn this episode, Dr. Valeria Santini, Associate Professor of Hematology at the University of Florence Medical School in Florence, Italy, joins host Dr. Nikolaos Papadantonakis to discuss advances in lower‑risk MDS anemia  and review important MDS...





]]>2004false51fullhttps://www.spreaker.com/episode/allogeneic-stem-cell-transplant-for-mds-advanced-considerations-part-ii-mds-patient-family-report--69327617

]]>https://api.spreaker.com/episode/69327617Tue, 06 Jan 2026 19:25:04 +0000MDS FoundationIn this follow-up episode,  Dr. Nikolaos Papadantonakis continues the conversation with Dr. Colin Vale from Winship Cancer Institute of Emory University and Dr. Nancy Luna Torres from Moffitt Cancer Center, diving deeper into advanced transplant...

]]>1870false44fullhttps://www.spreaker.com/episode/allogeneic-stem-cell-transplant-for-mds-understanding-the-basics-part-i-mds-patient-family-report--69327570https://api.spreaker.com/episode/69327570Tue, 06 Jan 2026 19:21:51 +0000MDS FoundationJoin host Dr. Nikolaos Papadantonakis as he welcomes Dr. Colin Vale from Winship Cancer Institute of Emory University and Dr. Nancy Luna Torres from Moffitt Cancer Center to discuss the fundamentals of allogeneic hematopoietic stem cell...1833false43fullhttps://www.spreaker.com/episode/eha-2025-updates-mds-patient-family-report--67907493https://api.spreaker.com/episode/67907493Fri, 26 Sep 2025 11:27:41 +0000MDS FoundationThis episode features Dr. Nikolaos Papadantonakis from the Winship Cancer Institute of Emory University and Dr. Amer Zeidan from the Yale School of Medicine, discussing research on Myelodysplastic Syndromes (MDS) presented at the 2025 European...1385false42fullhttps://www.spreaker.com/episode/ash-2024-mds-in-focus-mds-patient-family-report--64559941
Tune in to gain valuable insights and stay informed about the evolving landscape of MDS management.]]>https://api.spreaker.com/episode/64559941Tue, 25 Feb 2025 11:14:00 +0000MDS FoundationJoin Dr. Madanat (UT Southwestern, Texas), Dr. Stahl (Harvard Medical School, Massachusetts), and Dr. Papadantonakis (Emory University, Georgia) as they break down key Myelodysplastic Syndromes (MDS) abstracts from the 2024 American Society of...
Tune in to gain valuable insights and stay informed about the evolving landscape of MDS management.]]>2047false41fullhttps://www.spreaker.com/episode/mds-highlights-of-the-2024-european-hematology-association-congress-mds-patient-family-report--62282516https://api.spreaker.com/episode/62282516Mon, 28 Oct 2024 14:00:02 +0000MDS FoundationDr. Rena Buckstein and Dr. Moshe Mittelman join Dr. Nikolaos Papadantonakis to discuss key MDS abstracts presented in the 2024 European Hematology Association Congress. Topics covered include anemia and the role of ivosidenib in higher risk MDS.2154false34fullhttps://www.spreaker.com/episode/introduction-to-cytogenetics-and-mutational-testing-in-mds-mds-patient-family-report--60801813https://api.spreaker.com/episode/60801813Mon, 29 Jul 2024 10:00:03 +0000MDS FoundationDr. Nikolaos Papadantonakis discusses cytogenetics and mutational testing in MDS with Dr. Hetty Carraway and Dr. Moshe Mittelman and how they utilize this information in the clinical setting.1807false33fullhttps://www.spreaker.com/episode/overview-of-mds-treatments-mds-patient-family-report--59725781https://api.spreaker.com/episode/59725781Tue, 30 Apr 2024 07:50:42 +0000MDS FoundationIn this episode, Dr. Papadantonakis from Winship Cancer Institute of Emory University, Atlanta, US, and Dr. Mittelman, chairman of the MDS Foundation scientific board, discuss the range of treatment options for patients with MDS. 1569false32fullhttps://www.spreaker.com/episode/new-drugs-for-anemia-of-lower-risk-mds-mds-patient-family-report--59194847https://api.spreaker.com/episode/59194847Wed, 27 Mar 2024 12:37:30 +0000MDS FoundationMDS experts Drs Nikolaos Papadantonakis of Emory, Atlanta, US, and Moshe Mittelman, Tel-Aviv, Israel, discuss new trials presented in the last meeting of the American Society of Hematology (ASH) 2023. They focus on luspatercept, imetelstat and...1638false31fullhttps://www.spreaker.com/episode/commonly-asked-questions-part-ii-mds-patient-family-report--58329649https://api.spreaker.com/episode/58329649Fri, 23 Feb 2024 04:00:02 +0000MDS FoundationMrs. Iris Yahal, founder and director of MDS Israel Support Group (Israel MDS Foundation), discusses with Dr. Moshe Mittelman of Tel-Aviv, an MDS expert, several issues that are within the interest of MDS patients and families, including issues...1296false24fullhttps://www.spreaker.com/episode/commonly-asked-questions-part-l-mds-patient-family-report--58329277https://api.spreaker.com/episode/58329277Fri, 26 Jan 2024 04:00:02 +0000MDS FoundationIn this part I of the frequently asked questions episode, Mrs. Iris Yahal, the founder and director of the MDS Israel Support Group (Israel MDS foundation), asks and discusses with Dr. Mittelman, of Tel-Aviv, several topics that are within the...1250false23fullhttps://www.spreaker.com/episode/clinical-trials-what-s-important-to-know-part-ii-mds-patient-family-report--58115149https://api.spreaker.com/episode/58115149Mon, 25 Dec 2023 13:27:33 +0000MDS FoundationMoshe Mittelman, Professor of Medicine and Hematology from Tel-Aviv and chairman, the scientific board of MDS Foundation, interviews Mrs. Noa Goldschmidt, Chief Study Coordinator in Tel-Aviv Sourasky Medical Center, about clinical trials from the...1244false22fullhttps://www.spreaker.com/episode/clinical-trials-what-s-important-to-know-part-i-mds-patient-family-report--57709915Program, Dr. Moshe Mittelman, Chief MDS Center of Excellence, Tel Aviv Sourasky
(Ichilov) Medical Center, Tel-Aviv, and Mrs. Noa Goldshmidt, Chief Study Coordinator
at TASMC, discussing various issues related to clinical trials. The episode is directed
to MDS patients, their families, and all interested parties, with a special focus on
clinical trials for MDS patients. Among other topics, they explain what clinical trials
are, why they are so important, they describe the stages and process of clinical
trials, and explain why patients can benefit from participation in trials. Finally, they
emphasize that patient safety is the prior interest and is highly maintained, and
provide some interesting real-world examples.]]>https://api.spreaker.com/episode/57709915Sun, 19 Nov 2023 14:39:45 +0000MDS FoundationIn this episode of the MDS-Foundation Podcast Projects – The Patient and Families Program, Dr. Moshe Mittelman, Chief MDS Center of Excellence, Tel Aviv Sourasky (Ichilov) Medical Center, Tel-Aviv, and Mrs. Noa Goldshmidt, Chief Study Coordinator at...Program, Dr. Moshe Mittelman, Chief MDS Center of Excellence, Tel Aviv Sourasky
(Ichilov) Medical Center, Tel-Aviv, and Mrs. Noa Goldshmidt, Chief Study Coordinator
at TASMC, discussing various issues related to clinical trials. The episode is directed
to MDS patients, their families, and all interested parties, with a special focus on
clinical trials for MDS patients. Among other topics, they explain what clinical trials
are, why they are so important, they describe the stages and process of clinical
trials, and explain why patients can benefit from participation in trials. Finally, they
emphasize that patient safety is the prior interest and is highly maintained, and
provide some interesting real-world examples.]]>1193false21fullhttps://www.spreaker.com/episode/blood-transfusions-and-quality-of-life-in-mds-mds-patient-family-report--53693531https://api.spreaker.com/episode/53693531Mon, 01 May 2023 10:00:02 +0000MDS FoundationProf. Rena Buckstein from Toronto, and Prof. Moshe Mittelman from Tel-Aviv discuss the role of blood transfusions and issues related to quality of life in patients with myelodysplastic syndromes (MDS), including reviewing the recent research in the field.1499false14fullhttps://www.spreaker.com/episode/bone-marrow-failure-disorders-in-childhood-mds-patient-family-report--52098677https://api.spreaker.com/episode/52098677Mon, 05 Dec 2022 13:11:20 +0000MDS FoundationProf. Akiko Shimamura of Harvard Medical School, Boston, a world known expert of pediatric hematology discusses with Prof. Guillermo Sanz ,of Valencia and Prof. Moshe Mittelman, of Tel Aviv, the various aspects of bone marrow failure including...1383false13fullhttps://www.spreaker.com/episode/personalized-treatment-of-mds-mds-patient-family-report--51403337https://api.spreaker.com/episode/51403337Wed, 28 Sep 2022 07:22:25 +0000MDS FoundationDrs. Rafael Bejar (San Diego) and Moshe Mittelman (Tel Aviv) discuss the trend towards adjusting the appropriate treatment to the particular MDS patient, a trend that is associated with higher rate of successful treatments and less toxicity. They also...1054false12fullhttps://www.spreaker.com/episode/mds-is-already-in-the-genetic-era-mds-patient-family-report--50254675First, they discuss the introduction of genetic tests into clinical practice of MDS. These tests found, for example, that at least a third of MDS patients with the TP53 mutation, do not (!) suffer from poor prognosis as previously thought. The new classification that will include genetic testing and will allow more accurate diagnosis leading to more appropriate treatment.
They then answer frequently asked questions: 1) MDS might be considered as cancer, but more important is the progress towards chronicity of the disease allowing many patients prolonged life expectancy with good quality of life. 2) In a reply to another common question: MDS is basically not an inherited disease ! In >90-95%, the disease is acquired.]]>https://api.spreaker.com/episode/50254675Sun, 19 Jun 2022 07:10:59 +0000MDS FoundationThe first episode of this program, brings a conversation between Prof. Guillermo Sanz from Valencia and Prof. Moshe Mittelman from Tel Aviv, on several issues relevant for patients, families and other stakeholders interested in myelodysplastic...First, they discuss the introduction of genetic tests into clinical practice of MDS. These tests found, for example, that at least a third of MDS patients with the TP53 mutation, do not (!) suffer from poor prognosis as previously thought. The new classification that will include genetic testing and will allow more accurate diagnosis leading to more appropriate treatment.
They then answer frequently asked questions: 1) MDS might be considered as cancer, but more important is the progress towards chronicity of the disease allowing many patients prolonged life expectancy with good quality of life. 2) In a reply to another common question: MDS is basically not an inherited disease ! In >90-95%, the disease is acquired.]]>1567false11full